ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Arkvax Limited

Arkvax Limited is an active company incorporated on 22 October 2020 with the registered office located in London, Greater London. Arkvax Limited was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12966888
Private limited company
Age
5 years
Incorporated 22 October 2020
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 13 November 2025 (2 months ago)
Next confirmation dated 13 November 2026
Due by 27 November 2026 (10 months remaining)
Last change occurred 19 days ago
Accounts
Submitted
For period 1 Nov31 Oct 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
London School Of Hygiene And Tropical Medicine
Keppel Street
London
WC1E 7HT
Address changed on 12 Jan 2023 (3 years ago)
Previous address was Moneta Building Babraham Research Campus Cambridge CB22 3AT United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
6
Shareholders
11
Controllers (PSC)
1
PSC • Director • Italian • Lives in England • Born in Apr 1978
Director • Dutch • Lives in Belgium • Born in Aug 1957
Director • British • Lives in UK • Born in Aug 1962
Director • British • Lives in United States • Born in May 1992
Director • French • Lives in England • Born in Jun 1972
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Beespoke Strategy Ltd
Dr Nazira Simin Amra is a mutual person.
Active
Blackhawk Innovation Limited
Dr Thomas Andrew Weaver is a mutual person.
Active
Cellcodex Technology Limited
Dr Thomas Andrew Weaver is a mutual person.
Active
Elijo Biotherapeutics Limited
Dr Thomas Andrew Weaver is a mutual person.
Active
White Pelican Innovation Ltd
Dr Jolyon Nicolas Edouard Martin is a mutual person.
Dissolved
Cellcodex Limited
Dr Thomas Andrew Weaver is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Oct 2024
For period 31 Oct31 Oct 2024
Traded for 12 months
Cash in Bank
£935.95K
Increased by £818.55K (+697%)
Turnover
Unreported
Same as previous period
Employees
5
Decreased by 1 (-17%)
Total Assets
£955.43K
Increased by £831.01K (+668%)
Total Liabilities
-£842.36K
Increased by £585.59K (+228%)
Net Assets
£113.07K
Increased by £245.42K (-185%)
Debt Ratio (%)
88%
Decreased by 118.21% (-57%)
Latest Activity
Confirmation Submitted
19 Days Ago on 6 Jan 2026
Accounting Period Extended
1 Month Ago on 23 Dec 2025
Dr Jolyon Nicolas Edouard Martin Details Changed
1 Month Ago on 1 Dec 2025
Full Accounts Submitted
5 Months Ago on 30 Jul 2025
Franciscus Dirven Appointed
6 Months Ago on 18 Jul 2025
Chariot Innovations Limited (PSC) Resigned
8 Months Ago on 22 May 2025
Dr Thomas Andrew Weaver Appointed
9 Months Ago on 8 Apr 2025
Confirmation Submitted
1 Year 2 Months Ago on 13 Nov 2024
Nicholas George Stern Resigned
1 Year 3 Months Ago on 30 Sep 2024
Dr Jon Cuccui (PSC) Details Changed
2 Years 1 Month Ago on 27 Dec 2023
Get Credit Report
Discover Arkvax Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 13 November 2025 with updates
Submitted on 6 Jan 2026
Change of details for Dr Jon Cuccui as a person with significant control on 27 December 2023
Submitted on 27 Dec 2025
Cessation of Chariot Innovations Limited as a person with significant control on 22 May 2025
Submitted on 23 Dec 2025
Current accounting period extended from 31 October 2025 to 31 December 2025
Submitted on 23 Dec 2025
Director's details changed for Dr Jolyon Nicolas Edouard Martin on 1 December 2025
Submitted on 2 Dec 2025
Statement of capital following an allotment of shares on 22 May 2025
Submitted on 21 Nov 2025
Appointment of Dr Thomas Andrew Weaver as a director on 8 April 2025
Submitted on 11 Nov 2025
Appointment of Franciscus Dirven as a director on 18 July 2025
Submitted on 11 Nov 2025
Total exemption full accounts made up to 31 October 2024
Submitted on 30 Jul 2025
Memorandum and Articles of Association
Submitted on 10 Jun 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year